Hims & Hers Health Total Long Term Liabilities 2020-2024 | HIMS
Hims & Hers Health total long term liabilities from 2020 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
- Hims & Hers Health total long term liabilities for the quarter ending September 30, 2024 were $0.010B, a 246.81% increase year-over-year.
- Hims & Hers Health total long term liabilities for 2023 were $0.009B, a 30.49% increase from 2022.
- Hims & Hers Health total long term liabilities for 2022 were $0.007B, a 1.28% decline from 2021.
- Hims & Hers Health total long term liabilities for 2021 were $0.007B, a 97.31% decline from 2020.
| Hims & Hers Health Annual Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2023 | $9 |
| 2022 | $7 |
| 2021 | $7 |
| 2020 | $250 |
| 2019 | $199 |
| 2018 | $ |
| Hims & Hers Health Quarterly Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2024-09-30 | $10 |
| 2024-06-30 | $10 |
| 2024-03-31 | $10 |
| 2023-12-31 | $9 |
| 2023-09-30 | $3 |
| 2023-06-30 | $3 |
| 2023-03-31 | $7 |
| 2022-12-31 | $7 |
| 2022-09-30 | $5 |
| 2022-06-30 | $5 |
| 2022-03-31 | $6 |
| 2021-12-31 | $7 |
| 2021-09-30 | $12 |
| 2021-06-30 | $27 |
| 2021-03-31 | $34 |
| 2020-12-31 | $250 |
| 2020-09-30 | $198 |
| 2020-06-30 | $200 |
| 2020-03-31 | $200 |
| 2019-12-31 | |
| 2019-09-30 | $198 |
| 2019-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $5.534B | $0.872B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $9.226B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.656B | 176.38 |
| Enovis (ENOV) | United States | $2.608B | 17.68 |
| Privia Health (PRVA) | United States | $2.587B | 215.60 |
| IRhythm Technologies (IRTC) | United States | $2.316B | 0.00 |
| Azenta (AZTA) | United States | $2.209B | 110.15 |
| Omnicell (OMCL) | United States | $2.116B | 69.23 |
| 10x Genomics (TXG) | United States | $1.732B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.689B | 0.00 |
| Schrodinger (SDGR) | United States | $1.518B | 0.00 |
| Phreesia (PHR) | United States | $1.148B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.690B | 0.00 |
| Standard BioTools (LAB) | United States | $0.596B | 0.00 |
| Talkspace (TALK) | United States | $0.583B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.547B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.505B | 87.40 |
| Health Catalyst (HCAT) | United States | $0.495B | 0.00 |
| Pulmonx (LUNG) | United States | $0.268B | 0.00 |
| TruBridge (TBRG) | United States | $0.247B | 71.91 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
| American Well (AMWL) | United States | $0.124B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.112B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.076B | 0.00 |
| HeartBeam (BEAT) | United States | $0.074B | 0.00 |
| 111 (YI) | China | $0.052B | 0.00 |
| CareCloud (CCLD) | United States | $0.046B | 0.00 |
| Outset Medical (OM) | United States | $0.044B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| Zepp Health (ZEPP) | China | $0.037B | 0.00 |
| Movano (MOVE) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.013B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |